News Sentiment

BIOPOR sentiment intelligence

BioPorto A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 4 relevant articles
Exchange CPH Denmark
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 1.17 Week of 19 Jun 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

65/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-0.8% over one week, -6.0% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback

Market Reaction

Balanced read

43/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 65/100 classification
One-week reaction -0.8% Price digesting
Trend fit Trend active -6.0% over four weeks
Fair value -23.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
The Manila Times 2
Seeking Alpha 1
Via Ritzau 1

Event Lens

What the news is about

Classified themes
Market update 2
Earnings 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4
Via Ritzau Direct company coverage

BioPorto A/S

Tone
Neutral 50/100
Event
Market update
Published
05 Feb 2026 08:00
Source
Via Ritzau